Arcellx (ACLX) Current Leases (2022 - 2025)
Arcellx's (ACLX) quarterly Current Leases came in at $7.5 million in Q3 2025, up 3.01% year-on-year from $7.3 million in Q3 2024, and up 1.49% quarter-over-quarter from $7.4 million in Q1 2025.
Arcellx (ACLX) Current Leases (2022 - 2025) Analysis & Trends
Arcellx's Current Leases history runs 4 years deep, the most recent figure standing at $7.5 million for Q3 2025.
- On a quarterly basis, Current Leases rose 3.01% year-over-year to $7.5 million in Q3 2025; TTM through Sep 2025 was $7.5 million, a 3.01% increase from a year earlier, with the FY2024 full-year figure at $7.3 million, down 81.4% from the prior year.
- Current Leases grew to $7.5 million in Q3 2025 per ACLX's latest filing, from $7.4 million in the prior quarter.
- Across five years, Current Leases topped out at $48.3 million in Q3 2023 and bottomed at $737000.0 in Q1 2022.
- The 4-year median for Current Leases is $7.3 million (2024), against an average of $15.8 million.
- Across the five-year window, Current Leases jumped 1580.1% in 2023 and plunged 84.98% in 2024, its largest moves.
- Year by year, Current Leases stood at $2.9 million in 2022, then jumped by 1254.12% to $39.3 million in 2023, then sank by 81.4% to $7.3 million in 2024, then rose by 2.23% to $7.5 million in 2025.
- Per Business Quant, the three latest ACLX Current Leases figures stand at $7.5 million (Q3 2025), $7.4 million (Q1 2025), and $7.3 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.47 Mn |
| Mar 31, 2025 | 7.36 Mn |
| Dec 31, 2024 | 7.31 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 19.22 Mn |
| Mar 31, 2024 | 32.53 Mn |
| Dec 31, 2023 | 39.28 Mn |
| Sep 30, 2023 | 48.29 Mn |
| Jun 30, 2023 | 38.05 Mn |
| Mar 31, 2023 | 4.95 Mn |
| Dec 31, 2022 | 2.90 Mn |
| Sep 30, 2022 | 2.87 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Mar 31, 2022 | 737,000.00 |